Connect your AI

Acadia Pharmaceuticals ACAD Gross Profit

Gross Profit at other companies

BiogenBIIB

$1.82B+0.8%

Catalyst PharmaceuticalCPRX

$134.92M+9.2%

Amneal Pharmaceuticals, Inc.AMRX

$320.11M+25.1%

Neurocrine BiosciencesNBIX

——

BridgeBio PharmaBBIO

——

TG TherapeuticsTGTX

——

Other financials

Income statement

Revenue$268.1M+9.7%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

$268.1Mtotal revenue−$24.8Mtotal cost of revenue=$243.27M

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Acadia Pharmaceuticals's gross profit?: Acadia Pharmaceuticals (ACAD) reported gross profit of $243.27M in Q1 2026.
How has Acadia Pharmaceuticals's gross profit changed year-over-year?: Acadia Pharmaceuticals's gross profit increased by 8.6% year-over-year, from $223.93M to $243.27M.
What is the long-term trend for Acadia Pharmaceuticals's gross profit?: Over 4 years (2021 to 2025), Acadia Pharmaceuticals's gross profit has grown at a 20.6% compound annual growth rate (CAGR), from $465M to $982.51M.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.